CBOE vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 23, 2026

CBOE

59.8
AI Score
VS
CME Wins

CME

60.8
AI Score

Investment Advisor Scores

CBOE

Mar 23, 2026
60score
Recommendation
HOLD

CME

Mar 23, 2026
61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CBOE CME Winner
Forward P/E 25.641 26.1097 CBOE
PEG Ratio 3.6196 5.8703 CBOE
Revenue Growth 8.7% 8.0% CBOE
Earnings Growth 60.5% 35.0% CBOE
Tradestie Score 59.8/100 60.8/100 CME
Profit Margin 23.3% 62.6% CME
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD BUY CME

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.